Study of the relationship between antiemetic effect of Aprepitant and plasma concentration of Aprepitant
Not Applicable
- Conditions
- Malignant tumor(esophageal cancer,gastric cancer etc.)
- Registration Number
- JPRN-UMIN000007048
- Lead Sponsor
- Toho University School of Pharmaceutical Sciences Department of Clinical Pharmaceutics
- Brief Summary
o significant differences were found between the two groups in the percentage of CINV prevention. Of the 13 patients who experienced CINV, the highconcentration group showed a significant improvement in CINV during the aprepitant administration term.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Receiving an antiemetic drug 2)Receiving an opioid 3)Any patients judged by the investigator to be unfit to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method